155
Participants
Start Date
March 31, 2009
Primary Completion Date
January 31, 2011
Study Completion Date
June 30, 2012
FOLFIRI
"Day 1 of each Cycle~Combination Therapy of:~irinotecan 180 mg/m2 90-minute infusion leucovorin 400 mg/m2 2 hour infusion 5-FU 400 mg/m2 IV bolus 5-FU 2,400 mg/m2 46-48 hour infusion"
AMG 655
AMG 655 is an investigational, fully human, monoclonal antibody that selectively binds to Death Receptor-5 (DR-5)
Placebo
Inactive dummy agent (to maintain blind)
AMG 479
AMG 479 is an investigational, fully human, monoclonal antibody that binds with Insulin-like growth factor receptor type 1
Research Site, Budapest
Research Site, Szeged
Research Site, Pécs
Research Site, Győr
Research Site, New York
Research Site, Orbassano
Research Site, Hudson
Research Site, Genova
Research Site, Philadelphia
Research Site, Philadelphia
Research Site, Milan
Research Site, Roanoke
Research Site, High Point
Research Site, Madrid
Research Site, Madrid
Research Site, Atlanta
Research Site, Pamplona
Research Site, Bordeaux
Research Site, Miami
Research Site, Ocala
Research Site, Port Saint Lucie
Research Site, Paducah
Research Site, Columbus
Research Site, Fishers
Research Site, Lille
Research Site, Joliet
Research Site, Chicago
Research Site, Wichita
Research Site, Lyon
Research Site, Dallas
Research Site, Tyler
Research Site, Temple
Research Site, Austin
Research Site, Amarillo
Research Site, Denver
Research Site, Denver
Research Site, Los Angeles
Research Site, Beverly Hills
Research Site, Boulogne-Billancourt
Research Site, Santa Maria
Research Site, Moscow
Research Site, Singapore
Research Site, Arkhangelsk
Research Site, Singapore
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Obninsk
Research Site, Kursk
Research Site, Singapore
Research Site, Samara
Research Site, Ufa
Research Site, Worcester
Research Site, Lebanon
Research Site, New Territories
Research Site, Hyderabad
Research Site, Mumbai
Research Site, Nagpur
Research Site, Nashik
Research Site, Pune
Research Site, Kolkata
Research Site, Bangalore
Research Site, Gdansk
Research Site, Gliwice
Research Site, Opole
Research Site, Barcelona
Research Site, Barcelona
Research Site, L'Hospitalet de Llobregat
Lead Sponsor
NantCell, Inc.
INDUSTRY